Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sequential receptor–mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment

(2021) Jingmin Shen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Prostate cancer

(2021) Shahneen Sandhu et al.   LANCET

Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor‐Enhanced Chemo‐Immunotherapy for Optimizing Cancer Immunotherapy

(2021) Kai Sun et al.   Small

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

(2020) Isaure Vanmeerbeek et al.   OncoImmunology

Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma

(2020) Zhuo Yu et al.   ACS Nano

Dendritic Cells and Their Role in Immunotherapy

(2020) Alycia Gardner et al.   Frontiers in Immunology

A novel inhibitor of HSP70 induces mitochondrial toxicity and immune cell recruitment in tumors

(2020) Thibaut Barnoud et al.   CANCER RESEARCH

PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases

(2020) Jiang Ni et al.   JOURNAL OF CONTROLLED RELEASE

Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects

(2019) Mian Yu et al.   JOURNAL OF CONTROLLED RELEASE

A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy

(2019) Tong Qi et al.   BIOMATERIALS

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

(2019) Ronald de Wit et al.   NEW ENGLAND JOURNAL OF MEDICINE

Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies

(2019) Yun-Chieh Sung et al.   Nature Nanotechnology

Autophagy balances inflammation in innate immunity

(2018) Vojo Deretic et al.   Autophagy

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

(2018) Dai Fukumura et al.   Nature Reviews Clinical Oncology

Life, death and autophagy

(2018) Johnna Doherty et al.   NATURE CELL BIOLOGY

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

(2017) Jianqin Lu et al.   Nature Communications

Immunotherapy for prostate cancer: False promises or true hope?

(2016) Brian T. Rekoske et al.   CANCER

Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy

(2015) John A. Brockman et al.   EUROPEAN UROLOGY

Danger signalling during cancer cell death: origins, plasticity and regulation

(2013) A D Garg et al.   CELL DEATH AND DIFFERENTIATION

Immunogenic Cell Death in Cancer Therapy

(2012) Guido Kroemer et al.   Annual Review of Immunology

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

(2012) J. Hrkach et al.   Science Translational Medicine

Autophagy in immunity and inflammation

(2011) Beth Levine et al.   NATURE

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

(2011) M. Michaud et al.   SCIENCE

The Skin Cancer Chemotherapeutic Agent Ingenol-3-Angelate (PEP005) Is a Substrate for the Epidermal Multidrug Transporter (ABCB1) and Targets Tumor Vasculature

(2010) Luowei Li et al.   CANCER RESEARCH

Chemical modulators of autophagy as biological probes and potential therapeutics

(2010) Angeleen Fleming et al.   Nature Chemical Biology

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

(2009) François Ghiringhelli et al.   NATURE MEDICINE

Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies

(2009) Thuy T.T. Le et al.   VACCINE